Gu FM - Search Results

1

Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy.

Zhou D, Gu FM, Gao Q, Li QL, Zhou J, Miao CH. Zhou D, et al. Among authors: gu fm. World J Gastroenterol. 2012 Jun 28;18(24):3089-98. doi: 10.3748/wjg.v18.i24.3089. World J Gastroenterol. 2012. PMID: 22791944 Free PMC article. Clinical Trial.

2

The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantation.

Xu M, Tan C, Zhou J, Huang X, Dai Z, Zhu H, Zhao Y, Gu F, Zhou S, Fan J. Xu M, et al. Transpl Immunol. 2010 Feb;22(3-4):165-71. doi: 10.1016/j.trim.2009.11.003. Epub 2009 Nov 14. Transpl Immunol. 2010. PMID: 19922796

3

Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.

Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, Gu FM, Li QL, Dai Z, Zhou J, Fan J. Huang XY, et al. Among authors: gu fm. Cancer. 2010 Dec 1;116(23):5440-51. doi: 10.1002/cncr.25485. Epub 2010 Aug 16. Cancer. 2010. PMID: 20715158 Free article.

4

Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.

Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J. Gu FM, et al. World J Gastroenterol. 2011 Sep 14;17(34):3922-32. doi: 10.3748/wjg.v17.i34.3922. World J Gastroenterol. 2011. PMID: 22025881 Free PMC article.

5

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.

Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J. Gu FM, et al. Mol Cancer. 2011 Dec 15;10:150. doi: 10.1186/1476-4598-10-150. Mol Cancer. 2011. PMID: 22171994 Free PMC article.

6

Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma.

Gu FM, Gao Q, Shi GM, Zhang X, Wang J, Jiang JH, Wang XY, Shi YH, Ding ZB, Fan J, Zhou J. Gu FM, et al. Ann Surg Oncol. 2012 Aug;19(8):2506-14. doi: 10.1245/s10434-012-2268-8. Epub 2012 Mar 13. Ann Surg Oncol. 2012. PMID: 22411204 Clinical Trial.

7

Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma.

Li QL, Gu FM, Wang Z, Jiang JH, Yao LQ, Tan CJ, Huang XY, Ke AW, Dai Z, Fan J, Zhou J. Li QL, et al. Among authors: gu fm. PLoS One. 2012;7(3):e33379. doi: 10.1371/journal.pone.0033379. Epub 2012 Mar 9. PLoS One. 2012. PMID: 22428038 Free PMC article.

8

Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase.

Yan J, Tan C, Gu F, Jiang J, Xu M, Huang X, Dai Z, Wang Z, Fan J, Zhou J. Yan J, et al. Liver Transpl. 2013 May;19(5):507-20. doi: 10.1002/lt.23619. Liver Transpl. 2013. PMID: 23408515 Free article.

9

An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma.

Jiang JH, Gao Q, Shen XZ, Yu Y, Gu FM, Yan J, Pan JF, Jin F, Fan J, Zhou J, Huang XW. Jiang JH, et al. Among authors: gu fm. Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):586-95. doi: 10.1016/j.clinre.2013.09.002. Epub 2013 Oct 25. Clin Res Hepatol Gastroenterol. 2013. PMID: 24209690

10

Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.

Jiang JH, Liu YF, Ke AW, Gu FM, Yu Y, Dai Z, Gao Q, Shi GM, Liao BY, Xie YH, Fan J, Huang XW, Zhou J. Jiang JH, et al. Among authors: gu fm. Hepatology. 2014 Jun;59(6):2216-27. doi: 10.1002/hep.27012. Epub 2014 May 2. Hepatology. 2014. PMID: 24425307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters